Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China; Institute of Nephrology, Peking University, Beijing, China; Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China.
Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China; Institute of Nephrology, Peking University, Beijing, China; Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China.
Kidney Int. 2019 Oct;96(4):1010-1019. doi: 10.1016/j.kint.2019.06.015. Epub 2019 Jul 10.
A genome-wide association study (GWAS) indicated that myeloperoxidase-ANCA associated vasculitis (AAV) is associated with HLA-DQ. However, susceptibility alleles in these loci have been under-investigated. Here we genotyped 258 Chinese patients with myeloperoxidase-AAV and 597 healthy control individuals at HLA DRB1, DQA1, DQB1 and DPB1, and extracted the encoded amino acid sequences from the IMGT/HLA database. The replication cohort included 97 cases and 107 controls. T cell epitopes of myeloperoxidase were predicted and docked to the HLA molecules. We found DQA1∗0302 (odds ratio 2.34 (95% confidence interval 1.75-3.14)) and DQB1∗0303 (odds ratio 1.89 (1.45-2.48)) were risk alleles for myeloperoxidase-AAV. They are in overt linkage disequilibrium (r 0.69) and the haplotype DQA1∗0302-DQB1∗0303 presents a significant risk (haplotype score 6.39) as well. Aspartate160 on the DQ α chain (odds ratio 2.06 (1.60-2.67)), encoded by DQA1∗0302, and isoleucine185 on the DQ β chain (odds ratio 1.73 (1.38-2.18)), encoded by DQB1∗0303, both located in the α2β2 domains, conferred significant risk for myeloperoxidase-AAV. Homologous modeling showed that DQα∗160D may confer susceptibility to myeloperoxidase-AAV by altering dimerization of the HLA molecules. Thus, more attention should be paid to the roles of amino acids in the α2β2 domains in addition to the α1β1 binding groove of HLA class II molecules.
一项全基因组关联研究(GWAS)表明,髓过氧化物酶-抗中性粒细胞胞质抗体相关性血管炎(AAV)与 HLA-DQ 相关。然而,这些基因座中的易感等位基因尚未得到充分研究。在此,我们对 258 例中国髓过氧化物酶-AAV 患者和 597 名健康对照个体进行了 HLA-DRB1、DQA1、DQB1 和 DPB1 的基因分型,并从 IMGT/HLA 数据库中提取编码的氨基酸序列。验证队列包括 97 例病例和 107 例对照。预测髓过氧化物酶的 T 细胞表位,并将其对接至 HLA 分子。我们发现 DQA1∗0302(比值比 2.34(95%置信区间 1.75-3.14))和 DQB1∗0303(比值比 1.89(1.45-2.48))是髓过氧化物酶-AAV 的风险等位基因。它们明显处于连锁不平衡状态(r=0.69),DQA1∗0302-DQB1∗0303 单体型也呈现显著风险(单体型评分 6.39)。DQA1∗0302 编码的 DQα 链上的天冬氨酸 160(比值比 2.06(1.60-2.67))和 DQB1∗0303 编码的 DQβ 链上的异亮氨酸 185(比值比 1.73(1.38-2.18)),均位于 α2β2 结构域,对髓过氧化物酶-AAV 具有显著的风险。同源建模表明,DQα∗160D 可能通过改变 HLA 分子二聚化而导致髓过氧化物酶-AAV 的易感性。因此,除了 HLA Ⅱ类分子的 α1β1 结合槽之外,还应更加注意 α2β2 结构域中氨基酸的作用。